Terms: = Breast cancer AND MITF, WS2A, ENSG00000187098, 4286
37 results:
1. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
2. GREB1 isoform 4 is specifically transcribed by mitf and required for melanoma proliferation.
Shinzawa K; Matsumoto S; Sada R; Harada A; Saitoh K; Kato K; Ikeda S; Hirayama A; Yokoi K; Tanemura A; Nimura K; Ikawa M; Soga T; Kikuchi A
Oncogene; 2023 Oct; 42(42):3142-3156. PubMed ID: 37658191
[TBL] [Abstract] [Full Text] [Related]
3. Integrative analyses of RNA-seq and ChIP-seq Reveal mitf as a Target Gene of TFPI-2 in MDA231 Cells.
Wang G; Zhang G; Zhu N; Zhu C; Kang M; Zuo G; Niu Z; Ye W; Tian B; Cai R
Biochem Genet; 2023 Oct; 61(5):1745-1757. PubMed ID: 36787085
[TBL] [Abstract] [Full Text] [Related]
4. CCN3/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer.
Son S; Kim H; Lim H; Lee JH; Lee KM; Shin I
Cell Death Dis; 2023 Feb; 14(2):81. PubMed ID: 36737605
[TBL] [Abstract] [Full Text] [Related]
5. Novel role of microphthalmia-associated transcription factor in modulating the differentiation and immunosuppressive functions of myeloid-derived suppressor cells.
Lee A; Park H; Lim S; Lim J; Koh J; Jeon YK; Yang Y; Lee MS; Lim JS
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36627143
[TBL] [Abstract] [Full Text] [Related]
6. Interaction between moxifloxacin and Mcl-1 and mitf proteins: the effect on growth inhibition and apoptosis in MDA-MB-231 human triple-negative breast cancer cells.
Beberok A; Rok J; Rzepka Z; Marciniec K; Boryczka S; Wrześniok D
Pharmacol Rep; 2022 Oct; 74(5):1025-1040. PubMed ID: 36045272
[TBL] [Abstract] [Full Text] [Related]
7. HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin.
Biondini M; Kiepas A; El-Houjeiri L; Annis MG; Hsu BE; Fortier AM; Morin G; Martina JA; Sirois I; Aguilar-Mahecha A; Gruosso T; McGuirk S; Rose AAN; Tokat UM; Johnson RM; Sahin O; Bareke E; St-Pierre J; Park M; Basik M; Majewski J; Puertollano R; Pause A; Huang S; Keler T; Siegel PM
Oncogene; 2022 Mar; 41(12):1701-1717. PubMed ID: 35110681
[TBL] [Abstract] [Full Text] [Related]
8. Endolysosomal Cation Channels and mitf in Melanocytes and Melanoma.
Abrahamian C; Grimm C
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356645
[TBL] [Abstract] [Full Text] [Related]
9. OncotypeDX© Recurrence Score in BRCA mutation carriers: a systematic review and meta-analysis.
Davey MG; Richard V; Lowery AJ; Kerin MJ
Eur J Cancer; 2021 Sep; 154():209-216. PubMed ID: 34284256
[TBL] [Abstract] [Full Text] [Related]
10. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
[TBL] [Abstract] [Full Text] [Related]
11. Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers.
Osmanbeyoglu HU; Shimizu F; Rynne-Vidal A; Alonso-Curbelo D; Chen HA; Wen HY; Yeung TL; Jelinic P; Razavi P; Lowe SW; Mok SC; Chiosis G; Levine DA; Leslie CS
Nat Commun; 2019 Sep; 10(1):4369. PubMed ID: 31554806
[TBL] [Abstract] [Full Text] [Related]
12. Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.
Elango R; Vishnubalaji R; Manikandan M; Binhamdan SI; Siyal AA; Alshawakir YA; Alfayez M; Aldahmash A; Alajez NM
Sci Rep; 2019 Sep; 9(1):13696. PubMed ID: 31548560
[TBL] [Abstract] [Full Text] [Related]
13. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of mitf.
Pradhan AK; Bhoopathi P; Talukdar S; Scheunemann D; Sarkar D; Cavenee WK; Das SK; Emdad L; Fisher PB
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5687-5692. PubMed ID: 30842276
[TBL] [Abstract] [Full Text] [Related]
14. Dedifferentiated Melanoma With Expression of Cytokeratin and GATA3 in a Patient With History of breast Carcinoma.
Alkhasawneh A; Nassri A; John I
Am J Dermatopathol; 2019 Jul; 41(7):502-504. PubMed ID: 30562218
[TBL] [Abstract] [Full Text] [Related]
15. Index report of cutaneous angiosarcomas with strong positivity for tyrosinase mimicking melanoma with further evaluation of melanocytic markers in a large angiosarcoma series.
Leon-Castillo A; Chrisinger JSA; Panse G; Samdani RT; Ingram DR; Ravi V; Prieto VG; Wang WL; Lazar AJ
J Cutan Pathol; 2017 Aug; 44(8):692-697. PubMed ID: 28556023
[TBL] [Abstract] [Full Text] [Related]
16. Identification, genetic testing, and management of hereditary melanoma.
Leachman SA; Lucero OM; Sampson JE; Cassidy P; Bruno W; Queirolo P; Ghiorzo P
Cancer Metastasis Rev; 2017 Mar; 36(1):77-90. PubMed ID: 28283772
[TBL] [Abstract] [Full Text] [Related]
17. New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis.
Rambow F; Job B; Petit V; Gesbert F; Delmas V; Seberg H; Meurice G; Van Otterloo E; Dessen P; Robert C; Gautheret D; Cornell RA; Sarasin A; Larue L
Cell Rep; 2015 Oct; 13(4):840-853. PubMed ID: 26489459
[TBL] [Abstract] [Full Text] [Related]
18. Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.
Ross JS; Badve S; Wang K; Sheehan CE; Boguniewicz AB; Otto GA; Yelensky R; Lipson D; Ali S; Morosini D; Chliemlecki J; Elvin JA; Miller VA; Stephens PJ
Arch Pathol Lab Med; 2015 May; 139(5):642-9. PubMed ID: 25927147
[TBL] [Abstract] [Full Text] [Related]
19. Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition.
Wadt KA; Aoude LG; Krogh L; Sunde L; Bojesen A; Grønskov K; Wartacz N; Ek J; Tolstrup-Andersen M; Klarskov-Andersen M; Borg Å; Heegaard S; Kiilgaard JF; Hansen TV; Klein K; Jönsson G; Drzewiecki KT; Dunø M; Hayward NK; Gerdes AM
PLoS One; 2015; 10(3):e0122662. PubMed ID: 25803691
[TBL] [Abstract] [Full Text] [Related]
20. Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.
Lorenzen S; Riera Knorrenschild J; Haag GM; Pohl M; Thuss-Patience P; Bassermann F; Helbig U; Weißinger F; Schnoy E; Becker K; Stocker G; Rüschoff J; Eisenmenger A; Karapanagiotou-Schenkel I; Lordick F
Eur J Cancer; 2015 Mar; 51(5):569-76. PubMed ID: 25694417
[TBL] [Abstract] [Full Text] [Related]
[Next]
